The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Toronto-Based PE Fund Imperial Capital Raises $126 million, Invests in IRB Company Schulman

Imperial Capital, a private equity fund in Toronto, Canada, closed its fourth fund yesterday with $126 million.  Interestingly, they kicked off Fund IV with an investment in Schulman Associates, an independent Institutional Review Board (IRB) company based in Cincinnati, Ohio, that provides:

“IRB services for a variety of study types (primarily Phase II and III multi-site clinical trials) within the United States, Puerto Rico, and Canada”

which will hopefully avoid any Coast-like problems.  Imperial Capital’s other current investments are in cosmetics, hair care and paintball. 

H/T to @CVCACanada.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers